International Journal of Cardiology Congenital Heart Disease
Scope & Guideline
Championing open access to vital cardiac research.
Introduction
Aims and Scopes
- Clinical Outcomes and Risk Assessment:
The journal consistently publishes studies that evaluate clinical outcomes in patients with congenital heart disease, assessing long-term survival, morbidity, and risk factors associated with various conditions. - Innovative Therapies and Surgical Techniques:
Research on new surgical techniques, catheter-based interventions, and pharmacological therapies is a core focus, highlighting advancements in treatment options for adult patients with congenital heart disease. - Patient-Centered Care and Quality of Life:
There is a strong emphasis on understanding the psychosocial impact of congenital heart disease, including studies on mental health, quality of life, and patient engagement in treatment decisions. - Epidemiology and Registry Studies:
The journal publishes research leveraging national and international registries to provide insights into the epidemiology of congenital heart disease, treatment trends, and outcomes across different populations. - Multidisciplinary Approaches to Care:
The journal supports the integration of various specialties in managing congenital heart disease, promoting studies that involve collaborative care models and the role of different healthcare professionals.
Trending and Emerging
- Telemedicine and Remote Care:
With the increasing reliance on telemedicine, especially during the COVID-19 pandemic, studies exploring the efficacy and patient experiences with remote care are gaining prominence. - Mental Health and Psychosocial Support:
There is a growing body of literature focusing on the mental health and psychosocial aspects of living with congenital heart disease, highlighting the importance of comprehensive care that addresses these needs. - Interdisciplinary Collaboration in Care:
Emerging studies emphasize the importance of interdisciplinary approaches to patient care, with a focus on how collaboration among cardiologists, surgeons, psychologists, and other health professionals can improve outcomes. - Longitudinal Studies and Life Course Perspectives:
Research examining the long-term outcomes and quality of life across different life stages is trending, reflecting a shift towards understanding the lifelong impact of congenital heart disease. - Innovative Diagnostic Tools and Techniques:
Recent publications are increasingly featuring studies on novel diagnostic approaches, including advanced imaging techniques and biomarkers, that enhance the management of congenital heart disease.
Declining or Waning
- Basic Science and Molecular Mechanisms:
Research focused on the basic science of congenital heart disease, including genetic and molecular studies, has seen a decrease in publication frequency, possibly as the field shifts towards clinical applications and outcomes. - Pediatric-Centric Studies:
As the journal has increasingly emphasized adult congenital heart disease, studies centered solely on pediatric populations are becoming less frequent, reflecting a broader trend towards lifelong care models. - Traditional Surgical Approaches:
There is a noticeable decline in publications relating to conventional surgical approaches, as the focus has shifted towards minimally invasive techniques and new technologies that enhance patient outcomes.
Similar Journals
International Journal of Chronic Obstructive Pulmonary Disease
Empowering Research for Better Lung HealthThe International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.
Pulmonary Circulation
Transforming research into real-world pulmonary care.Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.
CLINICAL AND EXPERIMENTAL MEDICINE
Empowering Healthcare with Cutting-Edge InsightsClinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.
THERAPEUTIC APHERESIS AND DIALYSIS
Transforming patient care with insights from leading experts.THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.
World Journal for Pediatric and Congenital Heart Surgery
Exploring New Frontiers in Pediatric Heart SurgeryThe World Journal for Pediatric and Congenital Heart Surgery, published by SAGE Publications Inc, is an authoritative resource dedicated to advancing the field of pediatric and congenital heart surgery. Since its inception in 2010, this journal has carved a niche for itself in the realms of pediatrics, cardiology, and surgery, with impressive quartile rankings reflecting its growing influence: Q2 in Pediatrics, Perinatology and Child Health, and Q2 in Surgery, alongside Q3 placements in Cardiology and Cardiovascular Medicine. This journal, which holds the ISSN 2150-1351 and E-ISSN 2150-0136, serves as a vital platform for researchers, clinicians, and students who are passionate about improving outcomes in pediatric cardiac care. Despite being a subscription-based publication, the journal underscores its commitment to disseminating high-quality research and critical reviews aimed at fostering collaboration and innovation in this specialized field, making it an essential read for anyone involved in pediatric healthcare.
AMERICAN JOURNAL OF CARDIOLOGY
Leading the Charge in Cardiovascular Discovery and ExcellenceThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Cardiology and Therapy
Connecting researchers and clinicians for heart health advancement.Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
Fostering Excellence in Reproductive Medicine ResearchGYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.
Cardiology Journal
Exploring the future of cardiac science.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
Journal of Pediatric Urology
Connecting researchers and clinicians to elevate child health.Journal of Pediatric Urology is a leading academic journal dedicated to the intersection of pediatric medicine and urological science. Published by ELSEVIER SCI LTD, this esteemed journal provides a vital platform for the dissemination of innovative research and clinical advancements in the field. With a 2023 impact factor that places it within the Q2 quartile for Pediatrics, Perinatology and Child Health, and the Q1 quartile for Urology, it is recognized among the top-tier journals in both domains. The journal covers a broad spectrum of topics from minimally invasive surgical techniques to management strategies for congenital urological disorders. This makes it an invaluable resource for researchers, clinicians, and students who seek to improve pediatric urological care. As the journal continues to evolve, it aims to foster interdisciplinary collaboration that drives further advancements in pediatric health. For those looking to avoid publication barriers, the journal retains traditional access options while contributing to the global growth of pediatric urology research from its base in the Netherlands.